The Asia Pacific Thoracic Surgery Devices Market would witness market growth of 6.8% CAGR during the forecast period (2023-2030).
The aging of the population highlights the significance of patient-centered care and minimally invasive procedures. Patients who are elderly frequently favor procedures that reduce postoperative discomfort, complications, and extended hospital stays. These elements contribute to the growth of the market. The development of surgical technologies has significantly influenced the expansion of the market. Minimally invasive surgical techniques, which include video-assisted thoracoscopic surgery (VATS) and robotic-assisted surgery, have gained popularity due to reduced invasiveness and faster patient recoveries.
The demographic shift toward an aging population has contributed to the rise in thoracic conditions, necessitating surgical interventions. Older patients often have comorbidities that require advanced thoracic surgery devices for safer procedures. Greater patient awareness and information accessibility have led to early diagnosis and intervention, driving the need for thoracic surgery devices that can provide effective and minimally invasive solutions. The adoption of minimally invasive surgery techniques is a dominant trend in the thoracic surgery field. Patients prefer these procedures due to reduced pain, shorter recovery times, and smaller incisions.
According to the National Library of Medicine, China has a relatively high lung cancer mortality rate compared to other countries. Lung cancer mortality in China is anticipated to rise by almost 40% between 2015 and 2030. Lung cancer is one of the most common cancers in China. The disease affects a substantial portion of the population, and its incidence drives the need for surgical treatments. China has a growing number of skilled thoracic surgeons with access to state-of-the-art devices to perform complex procedures and ensure optimal patient outcomes. The rising prevalence of lung cancer in China significantly impacts the market in the region. With the rising hospital sector and the growing number of lung cancer cases across the Asia Pacific region, the market is estimated to grow in upcoming years.
The China market dominated the Asia Pacific Thoracic Surgery Devices Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $73.6 Million by 2030. The Japan market is registering a CAGR of 6.1% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 7.6% during (2023 - 2030).
Based on Surgery Type, the market is segmented into Lobectomy, Wedge Resection, Pneumonectomy, and Others. Based on Product, the market is segmented into Forceps, Graspers, Clamps & Staplers, Scissors, Spreaders, Needle Holders, and Others. Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Australia, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Global Thoracic Surgery Devices Market is Predict to reach $998.1 Million by 2030, at a CAGR of 6.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Cardiotrack, Intuitive Surgical, Inc., Richard Wolf GmbH, Grena Ltd., Dextera Surgical Inc. (Aesculap Inc.), Teleflex, Inc., Medela AG, LivaNova PLC, and Sklar Corporation.
By Surgery Type
By Product
By End-use
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
